2m 2m 2m 2m 2m 2m 2m
Aldeyra Therapeu (ALDX)
NASDAQ
$1.85-$0.01 (-0.59%)
Price as of Jun 03, 2026 7:59 PM EDT- $105.6MMarket Cap
- -30.21%1-Year Change
- BiotechnologyIndustry
Aldeyra Therapeu (ALDX)
$1.85-$0.01 (-0.59%)
ALDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.86 | ||
Change | -$0.02 (-1.20%) | ||
Open | $1.64 | ||
High | $1.87 | ||
Low | $1.59 | ||
Previous Close | $1.64 | ||
Volume | 2,026,974 | ||
30-Day Average Volume | 922,189 | ||
1-Week Change | -7.87% | ||
1-Month Change | 3.14% | ||
1-Year Change | -30.21% | ||
3-Year Change | -84.60% | ||
5-Year Change | -86.92% | ||
Fundamentals | |||
Shares Outstanding | 60.3M | ||
Total Assets | $66.5M | ||
Market Cap | $105.6M | ||
Enterprise Value | $55.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.5M | ||
Free Cash Flow | -$5.1M | ||
EBIT | -$3.5M | ||
EBITDA | -$3.4M | ||
Net Working Capital | $41.9M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -29 | ||
PEG | -1 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue